CEFDITOREN PIVOXIL
PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+13
PHARMA ROMLEV I
Indication
Haemophilus parainfluenzae chronic bronchitis
Haemophilus parainfluenzae chronic bronchitis refers to a lower respiratory tract infection in which the fastidious, Gram-negative bacterium *Haemophilus parainfluenzae* triggers an acute bacterial exacerbation in patients with preexisting chronic bronchitis or chronic obstructive pulmonary disease. Read more about Haemophilus parainfluenzae chronic bronchitis
48 drugs 37 manufacturers
Drugs that treat it
Common Haemophilus parainfluenzae chronic bronchitis therapies.
APP PHARMACEUTI
MOXIFLOXACIN HCL
PLAGUE·+31
CITRON PHARMA L
CEFUROXIME (cefuroxime axetil)
PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+24
KARALEX PHARMA,
MOXIFLOXACIN (moxifloxacin HCl in sodium acetate and sulfate,water,iso-osm)
QUINOLONES·PLAGUE·+31
APP/FRESENIUS K
AVELOX (moxifloxacin HCl)
PLAGUE·+31
Bayer HealthCare
MOXIFLOXACIN HCL
QUINOLONES·PLAGUE·+31
BRECKENRIDGE
MOXIFLOXACIN (moxifloxacin HCl in sodium chloride, iso-osmotic)
QUINOLONES·PLAGUE·+31
MYLAN INSTITUTI
CEFUROXIME (cefuroxime axetil)
BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+24
AHP
Filter & compare in the drug finder →Opens the drug finder with Haemophilus parainfluenzae chronic bronchitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHaemophilus parainfluenzae chronic bronchitis refers to a lower respiratory tract infection in which the fastidious, Gram-negative bacterium *Haemophilus parainfluenzae* triggers an acute bacterial exacerbation in patients with preexisting chronic bronchitis or chronic obstructive pulmonary disease.
Primarily affecting adults with compromised respiratory defenses and underlying airway disease, this clinical state involves bacterial proliferation within the tracheobronchial tree that intensifies mucosal inflammation and impairs mucociliary clearance.
Clinically, it is characterized by an acute worsening of baseline symptoms beyond typical day-to-day variations, defined by increased dyspnea, increased sputum volume, and increased sputum purulence.
- nih.gov
Haemophilus parainfluenzae chronic bronchitis refers to a lower respiratory tract infection in which the fastidious, Gram-negative bacterium *Haemophilus parainfluenzae* triggers an acute bacterial exacerbation in patients with preexisting chronic bronchitis or chronic obstructive pulmonary disease Primarily affecting adults with compromised respiratory defenses and underlying airway disease, this clinical state involves bacterial proliferation within the tracheobronchial tree that intensifies m...
- creative-diagnostics.com
Haemophilus parainfluenzae chronic bronchitis refers to a lower respiratory tract infection in which the fastidious, Gram-negative bacterium *Haemophilus parainfluenzae* triggers an acute bacterial exacerbation in patients with preexisting chronic bronchitis or chronic obstructive pulmonary disease Clinically, it is characterized by an acute worsening of baseline symptoms beyond typical day-to-day variations, defined by increased dyspnea, increased sputum volume, and increased sputum purulence
- fda.gov
Haemophilus parainfluenzae chronic bronchitis refers to a lower respiratory tract infection in which the fastidious, Gram-negative bacterium *Haemophilus parainfluenzae* triggers an acute bacterial exacerbation in patients with preexisting chronic bronchitis or chronic obstructive pulmonary disease
- ersnet.org
Primarily affecting adults with compromised respiratory defenses and underlying airway disease, this clinical state involves bacterial proliferation within the tracheobronchial tree that intensifies mucosal inflammation and impairs mucociliary clearance
- nih.gov
Primarily affecting adults with compromised respiratory defenses and underlying airway disease, this clinical state involves bacterial proliferation within the tracheobronchial tree that intensifies mucosal inflammation and impairs mucociliary clearance
- wustl.edu
Clinically, it is characterized by an acute worsening of baseline symptoms beyond typical day-to-day variations, defined by increased dyspnea, increased sputum volume, and increased sputum purulence
- ersnet.org
Clinically, it is characterized by an acute worsening of baseline symptoms beyond typical day-to-day variations, defined by increased dyspnea, increased sputum volume, and increased sputum purulence
Personalize your experience
Follow Haemophilus parainfluenzae chronic bronchitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.